Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question were fake after comparing them with actual batches. Alkem’s stock price saw a slight decline before closing marginally lower.
Related Posts
Tata Motors profit drops 10% to Rs3,450cr on weak demand
Tata Motors’ Q2 FY25 profit dropped by 10% to Rs 3,450 crore, falling short of analysts’ projections. This decline was driven by a 20% decrease […]
PAN 2.0: Have an extra PAN Card? Surrender now to avoid Rs 10,000 penalty! Check steps
The Indian government has launched PAN 2.0, a program to modernize and digitize PAN and TAN administration. It will consolidate services, enhance security with QR […]